As of January 22, 2025, Daiichi Sankyō (4568.T) has a market cap of $54.14 billion USD. According to our data, Daiichi Sankyō is ranked No.368 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $54.14 B |
2.87%
|
Dec 30, 2024 | $52.63 B |
13.78%
|
Dec 29, 2023 | $46.25 B |
-8.16%
|
Dec 30, 2022 | $50.36 B |
46.58%
|
Dec 30, 2021 | $34.36 B |
-16.54%
|
Dec 30, 2020 | $41.17 B |
48.01%
|
Dec 30, 2019 | $27.81 B |
108.56%
|
Dec 31, 2018 | $13.34 B |
21.61%
|
Dec 29, 2017 | $10.97 B |
26.20%
|
Dec 30, 2016 | $8.69 B |
-2.23%
|
Dec 30, 2015 | $8.89 B |
53.10%
|
Dec 30, 2014 | $5.81 B |
-9.17%
|
Dec 30, 2013 | $6.39 B |
50.33%
|
Dec 28, 2012 | $4.25 B |
-9.66%
|
Dec 30, 2011 | $4.71 B |
-10.81%
|
Dec 30, 2010 | $5.28 B |
-5.66%
|
Dec 30, 2009 | $5.59 B |
-3.49%
|
Dec 30, 2008 | $5.80 B |
-37.34%
|
Dec 28, 2007 | $9.25 B |
-5.75%
|
Dec 29, 2006 | $9.81 B |
66.71%
|
Dec 30, 2005 | $5.89 B |
2.71%
|
Dec 31, 2004 | $5.73 B |
16.20%
|
Dec 31, 2003 | $4.93 B |
14.15%
|
Dec 31, 2002 | $4.32 B |
-32.73%
|
Dec 31, 2001 | $6.42 B |
-24.40%
|
Dec 29, 2000 | $8.50 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Pfizer
PFE
|
$149.23 B |
0.006 M
|
USA
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
Novartis
NVS
|
$197.90 B |
0.005 M
|
Switzerland
|
GlaxoSmithKline
GSK
|
$68.43 B |
-0.001 M
|
UK
|
Sanofi
SNY
|
$128.49 B |
0.002 M
|
France
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
Bristol-Myers Squibb
BMY
|
$115.97 B |
0.003 M
|
USA
|
AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
Amgen
AMGN
|
$146.94 B |
0.008 M
|
USA
|
Takeda Pharmaceutical
TAK
|
$41.29 B |
-0.238 B
|
Japan
|
Gilead Sciences
GILD
|
$115.25 B |
-0.604 B
|
USA
|
Market Cap | = | 4568.T Stock Price | * | 4568.T Shares Outstanding |
= | $28.78 | * | 1.88 B | |
= | $54.14 B |